Skip to main content

ORIGINAL RESEARCH article

Front. Neurol.
Sec. Neurotrauma
Volume 15 - 2024 | doi: 10.3389/fneur.2024.1471209

THE IMPACT OF AGE AND INTENSITY OF TREATMENT ON THE OUTCOME OF TRAUMATIC BRAIN INJURY

Provisionally accepted
  • 1 Department of Interdisciplinary Medicine-Intensive Care Unit Section, University of Bari Aldo Moro, Bari, Italy
  • 2 Department of Intensive Care, Brussels’ University Hospital de Bruxelles (HUB), Brussels, Belgium
  • 3 IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Apulia, Italy
  • 4 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
  • 5 Anesthesia and Intensive Care Unit, Humanitas Gavazzeni, Bergamo, Lombardy, Italy
  • 6 Department of Neurosurgery, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium

The final, formatted version of the article will be published soon.

    Approximately one-third of trauma-related deaths are due to traumatic brain injury (TBI), particularly among young adults and elderly patients. Management strategies may vary across different age groups, potentially influencing short-term neurological outcomes. This study aims to investigate agerelated disparities in treatment approaches and 3-month neurological outcomes among TBI patients.We conducted a retrospective study on TBI patients requiring Intensive Care Unit (ICU) admission from January 1, 2015, to January 1, 2024, in a tertiary University hospital. Patient demographics, major comorbidities, ICU admission parameters, interventions and ICU complications were collected. An unfavorable neurological outcome at 3 months (UO) was defined as a Glasgow Outcome Scale (GOS) score of 1-3. A high therapy intensity level (TIL) was defined as a TIL basic of 3-4. A multivariable logistic regression model and a Cox proportional Hazard Regression model were used to assess the association of age and TIL with neurological outcome and mortality. A sensitivity analysis on low TIL (0-2) and high TIL subgroups was also conducted.We enrolled 604 TBI patients, of which 240 (40%) had UO. The highest prevalence of UO was found in patients aged 80 years (53/94, 56%), followed by patients aged 50-79 years (104/255, 41%). The age group 35-49 years had the lowest rate of UO (38/127,30%). Older patients (age 80 years) received less frequently high TIL than others (p=0.03). In the multivariable analysis, age 80 years (OR: 3.42 [95% CI 1.72 -6.81]) was independently associated with UO, while age 80 years (HR 5.42 [95% CI 3.00 -9.79]) and age 50-79 years (HR 2.03,) were independently associated with mortality. Although there was no interaction between age groups and TIL on outcome, an exploratory analysis showed that in the high TIL subgroup of patients, age had no independent impact on the outcome, whereas, in the low TIL group, age 80 years was independently associated with ).Older age, especially in the setting of low intensity treatment, may impact short-term neurological outcome of traumatic brain-injured patients.

    Keywords: Traumatic Brain Injury, age, Treatment, Mortality, neurological outcome, TBI, TIL

    Received: 26 Jul 2024; Accepted: 08 Nov 2024.

    Copyright: © 2024 Corriero, Fornaciari, Terrazzino, Zangari, Izzi, Peluso, Savi, Faso, Cavallini, Polato, Vitali, Schuind, Taccone and Bogossian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Alberto Corriero, Department of Interdisciplinary Medicine-Intensive Care Unit Section, University of Bari Aldo Moro, Bari, Italy
    Fabio Silvio Taccone, Department of Intensive Care, Brussels’ University Hospital de Bruxelles (HUB), Brussels, Belgium
    Elisa Gouvêa Bogossian, Department of Intensive Care, Brussels’ University Hospital de Bruxelles (HUB), Brussels, Belgium

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.